Indications and uses
for irrigating the eye to help relieve irritation, discomfort, burning, stinging, smarting, or itching by removing loose foreign material, air pollutants (smog or pollen), or chlorinated water.
for irrigating the eye to help relieve irritation, discomfort, burning, stinging, smarting, or itching by removing loose foreign material, air pollutants (smog or pollen), or chlorinated water.
Twist top to remove. Flush the affected eye as needed, controlling the rate of flow of solution by pressure on the bottle
Drug Facts
Purified water, 98.525%
eyewash
for irrigating the eye to help relieve irritation, discomfort, burning, stinging, smarting, or itching by removing loose foreign material, air pollutants (smog or pollen), or chlorinated water.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
benzalkonium chloride, edetate disodium, sodium chloride, sodium phosphate dibasic, sodium phosphate monobasic
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 42961-300-20 | 2025-02-12 | C162847 | 48780-1 | 1030e365-29d6-111a-e063-dadaa90a10e2 | First Aid Direct Buffered Eyewash Sterile Isotonic Solution |
| 42961-300-20 | 2024-01-30 | C162847 | 48780-1 | 1030e365-29d6-111a-e063-dadaa90a10e2 | First Aid Direct Buffered Eyewash Sterile Isotonic Solution |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Water | ACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| Water | ACTIVE MOIETY | 059QF0KO0R | 1 | |
| Benzalkonium chloride | INACTIVE INGREDIENT | F5UM2KM3W7 | 1 | |
| Edetate disodium | INACTIVE INGREDIENT | 7FLD91C86K | 1 | |
| Sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| Sodium phosphate, Dibasic, Heptahydrate | INACTIVE INGREDIENT | 70WT22SF4B | 1 | |
| Sodium phosphate, Monobasic, Monohydrate | INACTIVE INGREDIENT | 593YOG76RN | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 42961-300 | 42961-300-20 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Water | 059QF0KO0R | ACTIB |
| Benzalkonium chloride | F5UM2KM3W7 | IACT |
| Edetate disodium | 7FLD91C86K | IACT |
| Sodium chloride | 451W47IQ8X | IACT |
| Sodium phosphate, Dibasic, Heptahydrate | 70WT22SF4B | IACT |
| Sodium phosphate, Monobasic, Monohydrate | 593YOG76RN | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / EPIDURAL | 648 mg | ||
| Sodium phosphate, Dibasic, Heptahydrate | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | 70WT22SF4B | SPONGE / TOPICAL | 0.9 %w/w | ||
| Sodium phosphate, Dibasic, Heptahydrate | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | 70WT22SF4B | SOLUTION / AURICULAR (OTIC) | 0.5 %w/w | ||
| Edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / OPHTHALMIC | 4 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAVITREAL | 10 %w/v | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SHAMPOO / TOPICAL | 150 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAMUSCULAR | 1486 mg | ||
| Edetate disodium | EDETATE DISODIUM | 7FLD91C86K | CREAM, AUGMENTED / TOPICAL | 2 mg | ||
| Benzalkonium chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | INJECTION / INTRAMUSCULAR | 1 mg | ||
| Benzalkonium chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION / AURICULAR (OTIC) | 0.01 %w/v | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.8 %w/v | ||
| Sodium phosphate, Dibasic, Heptahydrate | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | 70WT22SF4B | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 3.43 mg | ||
| Edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / AURICULAR (OTIC) | 0.01 %w/v | ||
| Sodium phosphate, Dibasic, Heptahydrate | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | 70WT22SF4B | INJECTION / INTRABURSAL | ADJ PH | ||
| Sodium phosphate, Monobasic, Monohydrate | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 593YOG76RN | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 13.61 mg | ||
| Sodium phosphate, Monobasic, Monohydrate | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 593YOG76RN | SOLUTION / ORAL | 1500 mg | ||
| Sodium phosphate, Monobasic, Monohydrate | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 593YOG76RN | TABLET, DELAYED RELEASE / ORAL | 35 mg | ||
| Edetate disodium | EDETATE DISODIUM | 7FLD91C86K | CREAM / TOPICAL | 14 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / INTRAMUSCULAR | 9 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | DROPS / NASAL | NA | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PERIDURAL | 8.07 mg | ||
| Sodium phosphate, Dibasic, Heptahydrate | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | 70WT22SF4B | DOUCHE / VAGINAL | 0.15 %w/w | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAPERITONEAL | 226 mg | ||
| Sodium phosphate, Dibasic, Heptahydrate | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | 70WT22SF4B | CREAM / TOPICAL | 29 mg | ||
| Sodium phosphate, Dibasic, Heptahydrate | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | 70WT22SF4B | SOLUTION / OPHTHALMIC | 2.15 %w/v | ||
| Sodium phosphate, Dibasic, Heptahydrate | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | 70WT22SF4B | OINTMENT / TOPICAL | 0.15 %w/w | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / RESPIRATORY (INHALATION) | 43 mg | ||
| Benzalkonium chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | LIQUID / NASAL | 0.2 mg/1ml | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / ORAL | 148 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRAVENOUS | 2916 mg | ||
| Edetate disodium | EDETATE DISODIUM | 7FLD91C86K | LIQUID / NASAL | 2 mg/1ml | ||
| Edetate disodium | EDETATE DISODIUM | 7FLD91C86K | EMULSION / OPHTHALMIC | 0.3 %w/v | ||
| Edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / INTRAMUSCULAR | 4 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SUSPENSION / ENDOTRACHEAL | 46.76 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | TABLET / ORAL | 231 mg | ||
| Sodium phosphate, Monobasic, Monohydrate | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 593YOG76RN | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 15.55 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRASYNOVIAL | 0.9 %w/v | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INFILTRATION | 3535 mg | ||
| Sodium phosphate, Monobasic, Monohydrate | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 593YOG76RN | CAPSULE / ORAL | 600 mg | ||
| Edetate disodium | EDETATE DISODIUM | 7FLD91C86K | AEROSOL, FOAM / TOPICAL | 0.05 %w/w | ||
| Sodium phosphate, Dibasic, Heptahydrate | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | 70WT22SF4B | SUSPENSION / ORAL | 200 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / RESPIRATORY (INHALATION) | 108 mg | ||
| Benzalkonium chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SUSPENSION / OPHTHALMIC | 1 mg | ||
| Sodium phosphate, Dibasic, Heptahydrate | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | 70WT22SF4B | SUSPENSION/ DROPS / OPHTHALMIC | 0.48 %w/w | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRATHECAL | 1.35 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAPLEURAL | 226 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAVENOUS | 28773 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / IONTOPHORESIS | 0.6 %w/v | ||
| Edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION / SOFT TISSUE | 0.05 %w/v | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER / TOPICAL | NA | ||
| Edetate disodium | EDETATE DISODIUM | 7FLD91C86K | GEL / TOPICAL | 24 mg | ||
| Edetate disodium | EDETATE DISODIUM | 7FLD91C86K | AEROSOL, FOAM / RECTAL | 2 mg | ||
| Edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, EMULSION / INTRAVENOUS | 59 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / OPHTHALMIC | 10 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / TOPICAL | 0.86 %w/v | ||
| Sodium phosphate, Dibasic, Heptahydrate | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | 70WT22SF4B | INJECTION / INTRAMUSCULAR | 200 mg | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBARACHNOID | 0.9 %w/v | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR | 0.86 %w/v | ||
| Edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SPRAY / RESPIRATORY (INHALATION) | 0.05 %w/w | ||
| Sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / ORAL | 1126 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 4a0b0e8d-8c6a-4c81-b0c7-da5998b0ea9a | bffcb462-a237-43c2-8505-97a61ff1cc4d | 2025-02-12 | Warnings | bffcb462-a237-43c2-8505-97a61ff1cc4d |
Adverse event summaries are temporarily unavailable. Other product information remains available.